I think the thing holding us back is we only have the tow truck to some degree. Most of these other companies being used as comparisons seem to have the cpp and also the payload for certain diseases. I still find it hard to believe there is a company with a great drug that they have somehow proven would work if only they could get it into a cell. I guess omomyc was a classic example of this and why it generated interest, but who else is in the same boat. It seems a deal will most likely be generated by one of these current collaborations with an actual disease target
I think the thing holding us back is we only have the tow truck...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.24 |
Change
0.040(3.33%) |
Mkt cap ! $723.2M | |||
| Open | High | Low | Value | Volume |
| $1.20 | $1.24 | $1.19 | $1.500M | 1.241M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 204320 | $1.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 4333 | 2 |
View Market Depth
| Last trade - 16.11pm 24/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |